Sharp increase in profits at Siegfried Group

25-Mar-2003

Swiss pharmaceutical company The Siegfried Group has reported its best financial results in its 130-year history.

Swiss pharmaceutical company The Siegfried Group has reported its best financial results in its 130-year history.

In 2002 net turnover increased by 13.2% from Sfr352.6m (€239.5m) to Sfr399m (€271m), consolidated net profit rose by 66% to Sfr56.2m (€38.2m) and operating profit by 70.1% to Sfr75.4m (€51.2m).

The Siegfried Division contributed 91% of the group turnover and increased the consolidated turnover by 16.1% to Sfr362.4m (€246.2m). Much of this is attributable to the excellent results achieved by Siegfried Exclusives, which produces custom manufactured APIs for multinational pharmaceutical companies, and also to generic activities, the company said.

Sign up for your free email newsletter

Companies